Sono-Tek(SOTK.US)

Sono-Tek | 10-Q: FY2026 Q3 Revenue Misses Estimate at USD 5.004 M

Sono-Tek | 8-K: FY2026 Q3 Revenue Misses Estimate at USD 5.004 M

Sono-Tek misses Q3 revenue expectations, reiterates FY 2026 guidance

Sono-Tek reported a 4% year-over-year decline in Q3 revenue, missing analyst expectations with $5 million against a consensus of $5.24 million. Despite this, the company achieved a gross margin of 50% and a record backlog of $12.3 million. Sono-Tek reiterated its FY 2026 guidance, expecting modest revenue growth driven by demand in the medical device market, while facing challenges from clean energy declines and evolving tariff policies. Analysts maintain a "buy" rating, with a median 12-month price target of $7.75, reflecting a potential upside from its current price of $4.18.

Sono-Tek Q3 In-Line Coating Systems Sales Surge Over 20 Times to USD 1.8 Million

Sono-Tek Corporation (SOTK) reported a significant increase in Q3 sales, reaching USD 5.0 million, with a gross margin of 50%. Net income for the quarter was USD 1.2 million, with earnings per share at USD 0.08. For the nine-month period, net sales totaled USD 15.3 million, and the backlog hit a record USD 12.3 million. The company maintains its fiscal 2026 guidance, expecting modest revenue growth.

Sono-Tek Reports Fiscal Third Quarter and Nine-Month Fiscal 2026 Financial Results

Sono-Tek Corporation reported its fiscal third quarter and nine-month results for 2026, achieving over $5 million in revenue for the seventh consecutive quarter. Gross margin expanded to 50%, with net income rising 24% to $340,000. The company’s backlog reached a record $12.3 million, reflecting strong order momentum. Despite a decline in alternative energy sales, demand in the medical device market remains robust. Sono-Tek reiterated its guidance for modest revenue growth amid evolving market conditions.